https://pmc.ncbi.nlm.nih.gov/articles/PMC39899/
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth - PMC
Angiogenesis is activated during multistage tumorigenesis prior to the emergence of solid tumors. Using a transgenic mouse model, we have tested the...
antiangiogenic therapytransgenic micede novo
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1518217/full
Frontiers | Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint...
BackgroundAlthough immune checkpoint inhibitors (ICIs) and anti-angiogenic drugs have demonstrated effectiveness in treating advanced gastric cancer (GC), th...
neoadjuvant chemotherapyfrontierscombinedantiangiogenicimmune